Human Papillomavirus Vaccine Type11 L1Protien
Cervical carcinoma, human papillomavirus infections.
How it works
Human papillomavirus vaccine are designed to elicit virus-neutralizing antibody responses that prevent initial infection with the HPV types represented in the vaccine. The vaccines have been shown to offer 100 percent protection against the development of cervical pre-cancers and genital warts caused by the HPV types in the vaccine, with few or no side effects. The protective effects of the vaccine are expected to last a minimum of 4.5 years after the initial vaccination.
Common side effects
Dizziness, Fever, Injection site redness, Injection site soreness, Itching, Nausea, Swelling